1. Home
  2. RMBI vs IVA Comparison

RMBI vs IVA Comparison

Compare RMBI & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMBI
  • IVA
  • Stock Information
  • Founded
  • RMBI 1887
  • IVA 2011
  • Country
  • RMBI United States
  • IVA France
  • Employees
  • RMBI N/A
  • IVA N/A
  • Industry
  • RMBI Major Banks
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • RMBI Finance
  • IVA Health Care
  • Exchange
  • RMBI Nasdaq
  • IVA Nasdaq
  • Market Cap
  • RMBI 134.9M
  • IVA 117.3M
  • IPO Year
  • RMBI 2019
  • IVA 2020
  • Fundamental
  • Price
  • RMBI $13.19
  • IVA $2.16
  • Analyst Decision
  • RMBI
  • IVA Strong Buy
  • Analyst Count
  • RMBI 0
  • IVA 4
  • Target Price
  • RMBI N/A
  • IVA $13.25
  • AVG Volume (30 Days)
  • RMBI 15.7K
  • IVA 7.3K
  • Earning Date
  • RMBI 01-31-2025
  • IVA 09-25-2024
  • Dividend Yield
  • RMBI 4.25%
  • IVA N/A
  • EPS Growth
  • RMBI N/A
  • IVA N/A
  • EPS
  • RMBI 0.87
  • IVA N/A
  • Revenue
  • RMBI $42,258,740.00
  • IVA $20,652,523.00
  • Revenue This Year
  • RMBI N/A
  • IVA N/A
  • Revenue Next Year
  • RMBI N/A
  • IVA $361.78
  • P/E Ratio
  • RMBI $15.18
  • IVA N/A
  • Revenue Growth
  • RMBI N/A
  • IVA N/A
  • 52 Week Low
  • RMBI $10.11
  • IVA $1.53
  • 52 Week High
  • RMBI $15.15
  • IVA $4.50
  • Technical
  • Relative Strength Index (RSI)
  • RMBI 45.51
  • IVA 38.30
  • Support Level
  • RMBI $12.26
  • IVA $2.11
  • Resistance Level
  • RMBI $13.01
  • IVA $2.24
  • Average True Range (ATR)
  • RMBI 0.53
  • IVA 0.07
  • MACD
  • RMBI -0.05
  • IVA 0.01
  • Stochastic Oscillator
  • RMBI 53.73
  • IVA 22.07

About RMBI Richmond Mutual Bancorporation Inc.

Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: